をいずれか含む
  • 全て含む
  • いずれか含む
189468225

人間の医療廃棄物がサル痘のウイルス拡散に関与か、天然痘ワク …


このコンテンツは出版・報道コンテンツをご利用いただける
アカウントでログイン後に閲覧できます。
ご不明点はアフロカスタマーセンターまでお問い合わせ下さい。

ライトボックスに追加 カンプデータをダウンロードする 印刷

作品情報

作品番号
189468225
タイトル
人間の医療廃棄物がサル痘のウイルス拡散に関与か、天然痘ワクチンを製造するバイエルン・ノルディックの研究所
クレジット表記
動画:ロイター/アフロ
日付
2022年5月24日
撮影国
ドイツ
コンテンツカテゴリー
ヨーロッパ, ニュース
ライセンスタイプ
RM(ライツマネージド)
モデルリリース
なし 
プロパティリリース
なし 
コーデック
H264
フレームレート
25.00 fps
長さ
274.64 秒
もっと見る

ストーリー

Germany has ordered 40,000 doses of a Bavarian Nordic vaccine to be ready to vaccinate contacts of those infected with monkeypox if an outbreak in Germany becomes more severe, but officials are banking on other precautionary measures for now.
Bavarian Nordic, a vaccine company based in Denmark and the Bavarian capital of Munich, developed a vaccine based on the modified Vaccinia Ankara smallpox virus.
"The vaccine is certainly a further development of the conventional smallpox vaccines and is specifically designed to be a safer alternative," Heinz Weidenthaler, Bavarian Nordic's Vice President for Clinical Strategies told Reuters TV on Tuesday (May 24).
"The vaccine actually originated at the Bavarian State Vaccine Institute and was developed there in the 1960s and 1970s, when the vaccination campaign against the original smallpox was still ongoing", he added.
German Health Minister Karl Lauterbach earlier on Tuesday announced that that measures such as an isolation period of at least 21 days recommended for infected people would suffice for now to contain the outbreak.
He said the outbreak of monkeypox could be contained and did not signal the start of a new pandemic, adding that early intervention can prevent the pathogen from becoming firmly established in communities.
So far, five cases have been registered in Germany, all men, said Lothar Wieler, the head of Germany's Robert Koch Institute for infectious diseases, speaking at a joint news conference with Lauterbach.
A World Health Organization official on Monday issued similar guidance, saying the outbreak does not require mass vaccinations because measures like hygiene and safe sexual behaviour will help control the spread.
The WHO has registered more than 250 confirmed and suspected monkeypox infections, with a geographic spread that is unusual for the disease which is endemic in parts of west and central Africa but rare elsewhere. Many but not all of the cases have been reported in men who have sex with men, with the WHO targeting sexual transmission in particular.
(Production: Ayhan Uyanik, Louisa Off, Ulrike Heil)
( Original Title: Germany orders vaccine for monkeypox )
( Caption: 0334GE-HEALTH-MONKEYPOX_GERMANY_VACCINE_O_ )
もっと見る

タイムライン

MUNICH, GERMANY (MAY 24, 2022) (REUTERS)
VARIOUS OF BAVARIAN NORDIC STAFF WORKING WITH SAMPLES AT LABORATORY
VARIOUS OF BAVARIAN NORDIC PRINCIPAL SCIENTIST MARC SCHWENEKER SHOWING IMAGES OF MODIFIED VACCINIA ANKARA ON COMPUTER SCREEN
(SOUNDBITE) (German) AVARIAN NORDIC PRINCIPAL SCIENTIST MARC SCHWENEKER, SAYING:
"This is our household organism, the modified vaccinia Ankara, a pox virus - which we use as a vaccine - in the electron microscopic analysis, so that we can see that the structures are all well preserved and that the immunogen can then be used as a pox vaccine."
VARIOUS OF LABORATORY ASSISTANTS WORKING ON VACCINES, USING SMALLPOX SAMPLES
VARIOUS OF BAVARIAN NORDIC VICE PRESIDENT CLINICAL STRATEGIES, HEINZ WEIDENTHALER, LOOKING AT DOCUMENTS
(SOUNDBITE) (German) BAVARIAN NORDIC VICE PRESIDENT CLINICAL STRATEGIES, HEINZ WEIDENTHALER, SAYING:
"The vaccine is certainly a further development of the conventional smallpox vaccines and is specifically designed to be a safer alternative. The vaccine actually originated at the Bavarian State Vaccine Institute and was developed there in the 1960s and 1970s, when the vaccination campaign against the original smallpox was still ongoing. The aim of this vaccination campaign was to develop a safe alternative to these old, conventional vaccines. They are known as the old vaccines that leave the typical smallpox scar as they replicate in the skin."
LAB ASSISTANT TAKING SAMPLES
(SOUNDBITE) (German) BAVARIAN NORDIC VICE PRESIDENT CLINICAL STRATEGIES, HEINZ WEIDENTHALER, SAYING:
"As far as we can assess the situation today and as also all the health authorities currently are considering it, the vaccine is to be used for so-called ring vaccinations, which means it is targeted at people who may have been in contact and who are exposed to a risk. A broad mass vaccination is currently not recommended."
MORE OF SAMPLES
(SOUNDBITE) (German) BAVARIAN NORDIC VICE PRESIDENT CLINICAL STRATEGIES, HEINZ WEIDENTHALER, SAYING:
"This is a relatively classic vaccine. It is a real virus, but not this disease-causing virus, but a related virus from the same group of orthopox viruses, as we call it. This means that if you inoculate this weakened virus from the orthopox virus group, which is no longer capable of reproducing and does not cause disease, you have cross-immunity against all other exponents of the orthopox virus class. And these are the smallpox, the human smallpox, the monkeypox. In theory, they would also have this protection against cowpox, but that is not a problem."
VARIOUS OF LABORATORY ASSISTANT HOLDING GLASS WITH SMALLPOX VIRUS LIQUID
VARIOUS OF EXTERIOR OF BAVARIAN NORDIC HEADQUARTERS
もっと見る

サイズ

フレームサイズ
SD 864 × 486
形式
MP4

料金

プライスゾーン
Standard(料金案内)

ご利用上の注意

  • 被写体やご利用方法によっては、被写体管理者から事前に使用許可を得る必要がある場合があります。
  • 本作品を「TV番組・出版・報道・教育目的」以外でご使用の際は、事前申請が必要です。
    営利目的での使用をご検討の場合は、媒体に関わらずアフロカスタマーセンターまでお問合せください。

このコンテンツの
ご注文は電話・メールにて
承っております。

このコンテンツは、「使用に際して特別な注意事項がある」「別途著作権等の処理が必要」「準備に時間を要する」などの理由により、オンライン注文に対応していません。ご利用を希望される方はカスタマーセンターまでお問合せください。
アフロカスタマーセンター
営業時間<年中無休> 9:30~22:00
広告・販促・ウェブ
0120-565-410
sagasu@aflo.com
報道・出版・教育
0120-656-410
houdou@aflo.com
TV番組
0120-707-410
tv@aflo.com

キーワード

キーワードは画像や動画を検索するための便宜的なものであり、必ずしも画像や動画の内容を表すものではありません。
また、特定の思想やイメージを表すキーワードが付与されていても、そのキーワードと画像や動画の内容とを関連づける意図はないことにご留意ください。